ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2016 American Transplant Congress

    Recipient Age and KDPI Are Potent Predictors of Early Acute Rejection in the Modern Era of Deceased Donor Kidney Transplantation.

    D. Keith, G. Vranic, A. Nishio Lucar.

    Medicine, University of Virginia, Charlottesville, VA.

    The rate of acute rejection in the first six months after deceased donor (DD) kidney transplant is about 10% in the modern era of immunosuppression.…
  • 2016 American Transplant Congress

    A Quantitative CD45 Assay May Improve Diagnostic Accuracy of the Diagnosis of Acute Cellular Rejection in Transplant Kidney Biopsies.

    L. Laszik, S. Bowman, V. Walavalkar, F. Vincenti, Z. Laszik.

    UCSF, San Francisco.

    Purpose: We have previously shown that the total inflammatory load in transplant kidney biopsies (TxBx) can be determined with a high degree of accuracy using…
  • 2016 American Transplant Congress

    How Tacrolimus Variability Affects Donor Specific Antibodies, Rejection and Outcome After Kidney Transplantation.

    S. Papachristos, A. John Velvet, A. Summers, A. Tavakoli, R. Dhanda, R. Pararajasingam, B. Forgacs.

    Manchester Transplantation Unit, Manchester Royal Infirmary Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.

    Purpose:To investigate the effect of tacrolimus(tac) variability on the development of Donor Specific Antibodies(DSA),rejection and outcome in relation to Age, Gender, Ethnicity and Body Mass…
  • 2016 American Transplant Congress

    Randomized Controlled Trial of Mixed Acute Rejection Therapy in Renal Allografts: 3 Year Follow Up.

    A. Leino,1 A. Lichvar,1 B. Abu-Jawdeh,1 A. Govil,1 G. Mogilishetty,1 M. Cardi,2 J. Kremer,2 M. Cuffy,1 F. Paterno,1 R. Alloway,1 A. Shields,1,2 E. Woodle.1

    1U. of Cincinnati, Cincinnati; 2The Christ Hospital, Cincinnati.

    Optimal therapy for mixed acute rejection (MAR) (defined as coexisting acute cellular and antibody mediated rejection) has not been defined. Rabbit antithymocyte globulin (rATG) has…
  • 2015 American Transplant Congress

    Long Term Outcomes of Tocilizumab Therapy for DSA+ Antibody Mediated Rejection (ABMR) Resistant to IVIG + Rituxan (I+R) Treatment

    J. Choi,1 A. Vo,1 J. Kahwaji,1 M. Haas,2 N. Reinsmoen,3 D. Puliyanda,1 A. Peng,1 R. Villicana,1 S. Jordan.1

    1CTC, Cedars Sinai, Los Angeles, CA; 2Pathology, Cedars-Sinai, Los Angeles, CA; 3HLA Laboratory, Cedars-Sinai, Los Angeles, CA.

    Intro: Limited options are available for treatment of ABMR in highly-HLA sensitized patients (HS). Treatment options include I+R, PLEX+I+/- R, C5-inhibitor & bortezomib. Approximately 25%…
  • 2015 American Transplant Congress

    The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation

    S. Verma, Y. Tanaka, S. Shimizu, L. Das, H. Ohdan.

    Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Aim- Acute cellular rejection (ACR) accounts for 15-25% of graft failure in living donor liver transplantation (LDLT). T regulatory cells (Treg) play an important role…
  • 2015 American Transplant Congress

    CD3+CD4+ROR gamma t+ TH17 Cells Do Not Play a Critical Role in Islet Allograft Rejection

    M. Koulmanda, Z. Fan.

    Medicine, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.

    We have developed a “color-coded” adoptive transfer model for T cell subset identification that enables serial analysis of islet allograft infiltrating yellow induced regulatory T…
  • 2015 American Transplant Congress

    Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

    D. Glotz,1 G. Russ,2 L. Rostaing,3 C. Legendre,4 S. Chadban,5 J. Grinyo,6 N. Mamode,7 E. Cozzi,11 Y. Lebranchu,8 S. Sandrini,9 L. Couzi,12 W. Marks.10

    1H St-Louis, Paris, France; 2Ryl Adelaide H, Adelaide, Australia; 3CHU Rangueil, Toulouse, France; 4H Necker, Paris, France; 5Ryl Pr Alfred H, Camperdown, Australia; 6H U deBellvitge, Barcelona, Spain; 7Guy's H, London, United Kingdom; 8H Bretonneau CHU, Tours, France; 9Spedali Cvl di Brescia, Brescia, Italy; 10Alexion, Cheshire; 11Via Giustiniani, Padua, Italy; 12Hopital Pellegrin, CHU Bordeaux, Bordeaux, France.

    Complement activation by preformed DSA is a major mechanism of acute antibody-mediated rejection (aAMR) in sensitized kidney transplant recipients (KTR). We previously reported interim study…
  • 2015 American Transplant Congress

    Are AT1R Antibodies as Dangerous as HLA-DSAs in Renal Allografts?

    E. Cuevas, J. Arreola-Guerra, E. Hernandez-Mendez, I. Salcedo, M. Vilatoba, A. Contreras, A. Sanchez-Cedillo, J. Ramirez, D. de Rungs, J. Granados, L. Morales-Buenrostro, J. Alberu.

    1Transplantation, 1aNephrology-Mineral Metabolism, Inst Nal de Ciencias Medicas y Nutricion SZ, Mexico City, Distrito Federal, Mexico.

    Angiotensin II type 1 receptor antibodies (AT1Rab) have been associated with a significantly lower graft survival and a higher risk of acute rejection after kidney…
  • 2015 American Transplant Congress

    Association of De Novo Antibody-Mediated Rejection and Increased Hospital Costs Following Kidney Transplant in Immunologically Low-Risk Patients

    S. Kulkarni,1 I. Hall.2

    1Section of Organ Transplantation & Immunology, Yale University, New Haven, CT; 2Section of Nephrology, Yale University, New Haven, CT.

    While antibody-mediated rejection (AMR) is likely the primary cause of kidney transplant (KTx) failure, and its treatment can be considered expensive, incremental center costs for…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences